Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY – Get Free Report) was the target of a significant decline in short interest during the month of July. As of July 31st, there was short interest totaling 4 shares, a decline of 96.2% from the July 15th total of 106 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the company’s shares are short sold.
Ambu A/S Stock Performance
Shares of AMBBY opened at $10.86 on Thursday. The company’s fifty day simple moving average is $10.05 and its 200-day simple moving average is $10.85. The company has a market cap of $2.55 billion, a P/E ratio of 38.79 and a beta of 0.93. The company has a current ratio of 2.92, a quick ratio of 1.73 and a debt-to-equity ratio of 0.08. Ambu A/S has a twelve month low of $8.54 and a twelve month high of $16.78.
About Ambu A/S
Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.
Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.
See Also
- Five stocks we like better than Ambu A/S
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
